Special vaccines that use the body’s natural defense system to combat cancer. Dendritic cells are a specialized type of immune system cells. Dendritic cells initiate the immune response by processing antigen and presenting it to lymphocytes to stimulate production of more lymphocytes. BioPulse is one of the clinics on the forefront of this specialized technology.
VG-1000 Vaccine is a specialized vaccine developed by Dr. Valentin I. Govallo, MD, PhD, which undermines the cancer cells defense mechanisms. This vaccine is most beneficial in treating carcinomas and melanomas, and it is also indicated for some sarcomas (cancers of muscle, bone, and connective tissue) and in leukemia. Patients recently subjected to chemotherapy or radiation respond more slowly to VG-1000 as they have a depressed immune system. However, patients who have had neither radiation nor chemotherapy respond favorably. Thus VG-1000 is clearly indicated as first-line treatment for persons with recently diagnosed cancers, as well as to help prevent recurrence. This treatment is now available at two specialized facilities in North America, The Immuno-Augmentative Clinic in Freeport, Grand Bahamas, and also CHIPSA’s – Center for Integrative Medicine in Tijuana, Baja California, Mexico.
Recent Comments